MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases ...

Algernon Pharmaceuticals (AGNPF) is changing its name to Algernon Health. The planned name change reflects the Company’s recent announcement that ...

President Donald Trump's administration on Tuesday rolled out a memorandum aimed at limiting direct-to-consumer advertising for pharmaceuticals, with one senior administration official indicating that ...

The CALMA Phase 2 trial is a randomized, double-blind, placebo-controlled study designed to assess the safety and efficacy of IGC-AD1 in managing agitation in patients with Alzheimer's disease, a ...

Optimi Health ( ($TSE:OPTI) ) has issued an update. Optimi Health Corp. has launched its natural psilocybin capsules in Australia for the ...

This marks the first export of organic certified flower for SMGH, 20th international market for Aureus branded products and 23rd market for all ...

Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approvalStrategic partnership with Biocodex in biotherapeutics ...

Among the policy proposals in the report are the establishment of a National Institutes of Health Chronic Disease Task Force, ...

Health Minister Mark Butler has responded to chronic issues within the medicine access system by announcing a review of the ...

The three-day summit, scheduled for 19–21 September at Jio World Convention Centre, will bring global leaders to discuss ...

Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events. Medical affairs is evolving.

Plus, UTSW researcher wins Horwitz Prize and Qualthera's recent acquisition.